BRD2 and Alzheimer disease: After menopause, women exhibit up to tenfold higher levels of Luteinizing Hormone (LH) than men, and together with Follicle Stimulating Hormone (FSH), these gonadotropins exacerbate AD pathology, and FSH is specifically linked to cognitive impairment [145, 146].